Restructa pro injectione

Restructa pro injectione S

Structure:2.2 ml of the injection solution contain: Colchicum autumnale D4 0.143 g, Solidago virgaurea D3 0.083 g, Berberis vulgaris D4 0.143 g, Bryonia cretica D4 0.143 g, Calcium hypophosphorosum D3 0.083 g, Convallaria majalis D4 0.083 g, Echinacea angustifolia D4 Formica rufa D4 0.083 g, Formica rufa D6 0.083 g, Formica rufa D10 0.083 g, Ferrum phosphoricum D10 0.083 g, Lithium chloratum D3; 0.083 g, Toxicodendron quercifolium e summitatibus rec D4 0.146 g, Sarsaparilla D4 0.143 g, Salix alba D4 0.143 g, Coffeinum monohydricum D4 0.083 g, Cinchona succirubra D4 0.083 g, Acidum silicicum D8 0.083 g. qs sodium chloride solution

Indications Restructa about injection C / Restructa pro injectione S:

· uric acid diathesis;

· gout;

· urolithic diathesis;

· acute and chronic gouty arthritis.

Contraindications:the drug should not be prescribed during pregnancy and in patients with hypersensitivity to plants of the genus Rhus of the sumac family (Anacardiaceae): poisonous sumac, etc.

Side effects: not identified.

Dosage and route of administration of Restructa pro injectione S:

Single dose:for adults - usually 1 ampoule;children: up to 2 years from 1/6 to 1/4 of the contents of the ampoule, from 2 to 6 years - 1 / 3-1 / 2 of the volume of the ampoule, starting from 6 years - 1 ampoule.

The drug is administered parenterally - intramuscularly, intramuscularly, subcutaneously, including periarticularly or at acupuncture points (homeosiniatria), if necessary intravenously, 2-3 times a week, but not more than two injections per day . In an acute attack of gout - daily or every other day. If necessary; it is possible to take the drug in the form of "drinking ampoules".

Interaction with other drugs: without features.

Pharmacological properties of Restructa pro injectione S

An antihomotoxic drug Restrukt about injection C consists of18 potentiated plant, mineral and animal components.

These components are manufactured and combined in Restructs injection C injection using Fides unique homeopathic technology empirically developed through lengthy clinical trials.

Due to its unique composition and manufacturing technology, Restrukts injection drug C generally provides:

· normalizing (for uric acid metabolism);

· gouty;

· anti-inflammatory;

· immunocorrective;

· detoxification (matrix drainage);

· painkiller;

· diuretic effect.

General information

Impaired uric acid metabolism is the cause of gout. Slow excretion or excessive synthesis of uric acid from xanthines (purines) leads to hyperuricemia, uricosuria and is accompanied by the deposition of urate microcrystals in the joints, periarticular tissues, and in the urinary tract (urate stones).

Traditional drug therapy for gout is aimed at lowering uric acid levels in the blood with the help of xanthine oxidase inhibitors that limit the synthesis of uric acid, or drugs that block tubular reabsorption of uric acid in the kidneys, thus increasing its excretion. To stop an acute attack of gout, NSAIDs are used, in persistent cases, prednisone, triamcinolone, dexamethasone, intraarticular hydrocortisone are prescribed inside. All of the above groups of allopathic drugs due to their composition (chemical) and mechanism of action (blocking) have a number of contraindications and cause serious side effects, especially with prolonged use.

In this regard, the search for new methods and approaches in the complex treatment of gout does not stop, which, on the one hand, would increase the effectiveness of therapy, and on the other, would reduce the side effects, dosage and duration of taking uricosuric, NSAIDs, and corticosteroids.

AHTP initiate and activate those adaptive mechanisms of self-healing and self-healing of the body that have been lost or suppressed during life under the influence of various factors.

Restrukts drug about injection C has successfully passed clinical testing in the department of non-coronarogenic myocardial diseases and clinical rheumatology of the Institute of Cardiology named after N.D. Strazhesko AMS of Ukraine. This clinical trial was conducted as an open, comparative, parallel, randomized trial. It was attended by patients with a diagnosis of primary gout, mild to moderate severity in remission, gouty arthritis I-II art. activity, R? -st I-II, FSN I-II.

In patients who were prescribed Restrukts drug about injection C, in combination with allopurinol and diclofenac sodium, the effectiveness of the therapy was significantly increased (according to the final result). There was a more pronounced positive dynamics of laboratory and clinical indicators: there was a significant decrease in pain, an increase in the range of motion in the affected joints, increased performance (increased quality of life on the EuroQol-5D scale), a more pronounced decrease in uricemia, stabilization of urine pH within 6.2-7.0, the disappearance of microhematuria and proteinuria, a large percentage of patients with a decrease in size and softening of tofus, an increase in their mobility.

A multicentric study <Treatment of gouty arthritis with Restrukts injection of injection C - observation results> was carried out in Germany from February 1994 to April 1995, involving 151 patients. The results of this study showed that the use of the drug significantly reduced the patients need for allopathic drugs (analgesics / antirheumatic drugs) for gout. In this case, the drug was well tolerated by patients, did not have side effects.

Restruct about injection C:

- consists of potentiated plant, mineral and animal components;

- normalizes the metabolism of uric acid in the body;

- has a minimum of contraindications;

- has no side effects, as it acts according to the appropriate biological laws of the body itself;

- can be entered s / c and / c paraarticularly and at acupuncture points (homeosiniatria);

- reduces the need for analgesic / antirheumatic drugs.

Restructa about injection C is part of the mandatory range of pharmacies in Germany.